The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...

The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.

The Washington Post editorial board argued a federal judge's ruling against congressional Medicaid restrictions on abortion ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...

The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington Post reported on Friday, citing documents from the Centers for Medicare and ...

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...

UnitedHealth Group says it is cooperating with federal criminal and civil investigations involving its market-leading ...